Los Angeles Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258M Sell
4,257,069
-58,334
-1% -$3.4M 1.02% 14
2025
Q4
$197M Buy
4,315,403
+1,097,684
+34% +$52.8M 0.67% 30
2025
Q3
$145M Buy
3,217,719
+2,229,106
+225% +$104M 0.49% 40
2025
Q2
$45.8M Sell
988,613
-1,412,585
-59% -$69.3M 0.17% 109
2025
Q1
$146M Buy
2,401,198
+118,921
+5% +$6.93M 0.65% 34
2024
Q4
$129M Sell
2,282,277
-1,321,368
-37% -$73.8M 0.52% 43
2024
Q3
$186M Buy
3,603,645
+1,966,572
+120% +$92.3M 0.75% 25
2024
Q2
$68M Sell
1,637,073
-174,212
-10% -$7.8M 0.24% 83
2024
Q1
$98.2M Sell
1,811,285
-101,964
-5% -$5.19M 0.34% 67
2023
Q4
$98.2M Buy
1,913,249
+376,367
+24% +$19.8M 0.37% 67
2023
Q3
$89.2M Buy
1,536,882
+14,694
+1% +$900K 0.38% 58
2023
Q2
$97.3M Sell
1,522,188
-696,054
-31% -$46.7M 0.39% 60
2023
Q1
$154M Sell
2,218,242
-168,242
-7% -$11.9M 0.68% 32
2022
Q4
$172M Buy
2,386,484
+154,420
+7% +$11.6M 0.83% 27
2022
Q3
$159M Buy
2,232,064
+606,788
+37% +$44M 0.82% 23
2022
Q2
$125M Buy
1,625,276
+640,465
+65% +$48.8M 0.62% 33
2022
Q1
$71.9M Buy
984,811
+61,139
+7% +$4.11M 0.28% 86
2021
Q4
$57.6M Buy
923,672
+275,507
+43% +$16.2M 0.21% 99
2021
Q3
$38.4M Sell
648,165
-114,753
-15% -$7.56M 0.18% 116
2021
Q2
$51M Sell
762,918
-85,863
-10% -$5.6M 0.22% 104
2021
Q1
$53.6M Sell
848,781
-7,219
-0.8% -$449K 0.24% 97
2020
Q4
$53.1M Buy
856,000
+14,865
+2% +$914K 0.23% 98
2020
Q3
$50.7M Sell
841,135
-546,860
-39% -$32.9M 0.23% 100
2020
Q2
$81.6M Buy
1,387,995
+16,592
+1% +$992K 0.39% 57
2020
Q1
$76.4M Buy
1,371,403
+517,959
+61% +$31.7M 0.48% 50
2019
Q4
$54.8M Sell
853,444
-45,774
-5% -$2.62M 0.27% 97
2019
Q3
$45.6M Sell
899,218
-29,421
-3% -$1.38M 0.25% 105
2019
Q2
$42.1M Sell
928,639
-311,881
-25% -$14.5M 0.23% 106
2019
Q1
$59.2M Sell
1,240,520
-2,019,750
-62% -$101M 0.33% 67
2018
Q4
$169M Buy
3,260,270
+1,224,101
+60% +$65.8M 1.05% 13
2018
Q3
$126M Buy
2,036,169
+135,605
+7% +$8.05M 0.66% 22
2018
Q2
$105M Buy
1,900,564
+1,153,130
+154% +$62.3M 0.58% 22
2018
Q1
$47.3M Sell
747,434
-398,367
-35% -$25.6M 0.27% 103
2017
Q4
$70.2M Sell
1,145,801
-94,101
-8% -$5.89M 0.38% 62
2017
Q3
$79M Sell
1,239,902
-194,908
-14% -$11.4M 0.46% 44
2017
Q2
$79.9M Sell
1,434,810
-75,995
-5% -$4.14M 0.5% 36
2017
Q1
$82.2M Buy
1,510,805
+195,631
+15% +$10.7M 0.6% 28
2016
Q4
$76.9M Buy
1,315,174
+318,207
+32% +$17.4M 0.6% 25
2016
Q3
$53.8M Buy
996,967
+114,303
+13% +$7.34M 0.45% 45
2016
Q2
$64.9M Buy
882,664
+86,902
+11% +$6.14M 0.55% 39
2016
Q1
$50.8M Buy
795,762
+118,308
+17% +$7.46M 0.45% 55
2015
Q4
$46.6M Buy
677,454
+18,043
+3% +$1.19M 0.43% 65
2015
Q3
$39M Buy
659,411
+8,850
+1% +$561K 0.38% 72
2015
Q2
$43.3M Sell
650,561
-74,987
-10% -$4.94M 0.4% 63
2015
Q1
$46.8M Sell
725,548
-87,407
-11% -$5.47M 0.43% 59
2014
Q4
$48M Buy
812,955
+234,280
+40% +$13.2M 0.44% 61
2014
Q3
$29.6M Sell
578,675
-68,352
-11% -$3.41M 0.36% 81
2014
Q2
$31.4M Buy
647,027
+94,722
+17% +$4.67M 0.3% 95
2014
Q1
$28.7M Buy
552,305
+124,238
+29% +$6.61M 0.31% 89
2013
Q4
$22.8M Sell
428,067
-363,292
-46% -$18.5M 0.25% 131
2013
Q3
$36.6M Buy
791,359
+163,264
+26% +$7.17M 0.45% 50
2013
Q2
$28.1M Buy
+628,095
New +$27.3M 0.4% 54

Other funds holding BMY

Los Angeles Capital Management's BMY Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, selling an estimated $3.4M and leaving 4,257,069 shares worth $258M. The position accounts for 1.02% of the portfolio, ranked #14.

Los Angeles Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Los Angeles Capital Management held 4,257,069 shares of Bristol-Myers Squibb worth $258M as of Q1 2026.
  • Los Angeles Capital Management sold 58,334 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.4M.
  • Bristol-Myers Squibb made up 1.02% of Los Angeles Capital Management's portfolio in Q1 2026, its #14 holding.
  • Los Angeles Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.